NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is pleased to announce that it has commenced bottling 500mg and 1000mg full spectrum CBD distillate in the Company’s Augusta, Maine laboratory. The inaugural production will be to produce 2000 bottles per day with a gradual increase to 8000 bottles per day to fill demand. The CBD distillate will be distributed under HMPQ’s proprietary brand, “Weed Got Oil”.

Uptick Newswire Stock Day Podcast welcomed HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) an emerging leader in the CBD products market. CEO, Salvador Rosillo, joined Stock Day host Everett Jolly. To begin the interview Jolly asked Rosillo for an update on the Company’s projects since he was last on the show in October.

NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (HMPQ), (“HempAmericana” or the “Company”) is proud to update shareholders on an exciting weekend in which the Company made strong progress toward the launch of its new CBD product line at the 4th Annual High Times New York City Cannabis Film Festival (the “Festival”) and was featured in an “ELOCURE Cannabinoid Oil For Better Health” Publication that cited the Company’s strong strides as an emerging player in the CBD marketplace. Representatives from the Company had the chance to meet and be interviewed by a number of high-profile Cannabis publications as well as many mainstream publications. CEO Salvador Rosillo stated, “We expect a lot of strong coverage on the Company to come from our participation in this event.

NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company has signed a Letter of Intent (“LOI”) for the purchase of the entire crop of hemp flower from a key East Coast supplier. CEO, Salvador Rosillo stated, “My team and I will be traveling down to the site next week to meet with the team from the key supplier along with more than 40 other farmers in the region.

NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that it has partnered back up with High Times, the legendary leading brand in cannabis culture since 1974, as the Company kicks off its marketing campaign ahead of the start of full-scale CBD production at its state-of-the-art high capacity extraction and production facility in Augusta, Maine. As a start, the Company will join High Times as a sponsor at the 4th Annual High Times New York City Cannabis Film Festival (the “Festival”) this weekend, January 13, 2019.

First off, we wish to applaud members of the US House of Representatives and US Senate, as well as the President, for signing the 2018 Farm Bill into law last month. The removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA) will, according to all analysis we have received, indeed mean a broad expansion in the scale and scope of the total U.S. hemp industry.

CORAL GABLES, FL / ACCESSWIRE / December 12,2018 / The United States Senate passed the 2018 Farm Bill on Tuesday thus paving the way for CBD and hemp legalization. "Hemp products are made in America, sold in America, and consumed in America. Premier Health Group (PHGRF) (PHGI) announced this week that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy.

Four marijuana stocks to watch this month include Premier Health Group (PHGRF) (PHGI), HempAmericana, Inc (OTC PINK: HMPQ), Liberty Health Sciences Inc. (LHSIF) (LHS.CN) and Cronos Group Inc. (CRON). With the cannabis industry expected to reach $146.4 billion by end of 2025, according to a new report by Grand View Research, Inc, there will surely be a number of pot stocks to watch. Premier Health Group (PHGRF) (PHGI) announced today that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy.

CORAL GABLES, FL / ACCESSWIRE / December 11, 2018 / The North American marijuana industry is expected to see a near-term boom. A new report published by the firm shows the North America legal cannabis market value projected to reach around US$ 35 Billion by 2023, expanding at a CAGR of 27.1% during 2018-2023. The firm explains, "Nowadays, cannabis is gaining prominence in North America due to increasing acceptance of the drug for both recreational and medical uses.

NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is excited to announce the installation of a new high-precision Solvent Recovery Machine into the core processing and extraction equipment line at its state-of-the-art CBD production facility in Augusta, Maine. HempAmericana CEO, Salvador Rosillo, stated, “We are moving toward our goal of full-scale production of 99% pure CBD at high-capacity. With its new equipment engaged, the HempAmericana processing facility will have the means to cool biomass material and ethanol to a sub-zero level, slowing the solvency of ethanol and eliminating its ability to bind with water-based components, enabling the Company to process multiple batches each day, maximizing quality of concentrate and total output of CBD.

Planting took place from June 25 thru July 12, and harvest stretched from September 15 thru November 2 due to phenotypic variation, with distinctly different phenotypes represented for each strain grown. Total yield from this initial harvest is estimated at 4,000 lbs of hemp flower biomass produced from 3,831 harvested plants.

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun processing 4,100 lbs of in-house Hemp Flower inventory at its primary extraction and processing facility in Augusta, Maine. This initial production phase will output a high-quality raw biomass to be stored in cryo-freezers installed at the facility. CEO, Salvatore Rosillo stated, “It’s very gratifying to now have the team in place, the equipment fully up and running, and the raw flower finally being pushed through this state-of-the-art facility.

SeaThruEquity states in their Press Release to, “We initiate coverage on HempAmericana Inc. (OTC: HMPQ, $0.01) with a price target of $0.03. HempAmericana, Inc. is focused on research, development, and sale of industrial hemp-based products, which include rolling papers and CBD oils. CBD is one of the more than 85 cannabinoids identified in marijuana and hemp plants and is non-psychoactive with wide array of therapeutic benefits.

Salvador Rosillo, HempAmericana CEO, commented, “We are excited that SeeThruEquity has cast its light on HempAmericana and has recognized the remarkable growth potential we have ahead of us. The Company has recently completed a 24-month transition into the role of an emerging leader in high-capacity, high-quality CBD production. According to its report, these expectations are based on industry analysis and an in-depth analysis of HempAmericana’s strong financial position and state-of-the-art 17k sq. ft. production facility in Augusta, Maine.

NEW YORK, NY / ACCESSWIRE / November 7, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage HempAmericana, Inc. HempAmericana, Inc. is focused on research, development, and sale of industrial hemp-based products, which include rolling papers and CBD oils. CBD is one of the more than 85 cannabinoids identified in marijuana and hemp plants and is non-psychoactive with wide array of therapeutic benefits.

NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company is about to take delivery of the final two pieces of equipment necessary to complete its full production line. The Company has already been producing crude CBD. The installation of this new equipment will enable the Company to shift to production and bottling of refined, high-potency CBD Oil for immediate distribution and sale.